对心脏生物标志物和APACHE II评分进行比较评估,以预测第三级护理医院的败血症患者的预后
Shefali Meena1, C L Nawal2, Hazari L Saini3
1Junior Resident, Department of General Medicine, Sawai Man Singh Medical College, Jaipur, Rajasthan, India.
像proBNP这样的心脏生物标志物在预测败血症死亡率方面表现有前途,其表现与APACHE II得分相当. 对这些标记物的动态监测提供了比单次测量更好的预后洞察力.
科学领域:
- 心脏病学 心脏病学
- 关键护理医学 关键护理医学
- 生物标志物 生物标志物
背景情况:
- 败血症引起的心脏功能障碍是导致死亡的主要原因.
- 像APACHE II这样的既定预后得分在预测败血症结果方面存在局限性.
- 心脏生物标志物为预后提供了潜在的新途径.
研究的目的:
- 评估心脏生物标志物 (CPK-MB,Trop I,proBNP) 在败血症中的预后作用.
- 将这些生物标志物的预测准确性与APACHE II评分进行比较.
- 评估动态生物标志物监测对败血症预后的有用性.
主要方法:
- 一项涉及126名患者的病例控制研究 (63例败血症病例,63例对照).
- 包括心脏生物标志物:肌酸酸酶-心肌带 (CPK-MB),热素I (Trop I) 和proBNP.
- 对APACHE II评分的评估进行比较.
主要成果:
- 与对照组相比,败血症患者的心脏生物标志物显著增加.
- 不幸幸存者中的生物标志物水平高于败血症组中的幸存者.
- 亲大脑尿性 (proBNP) 与死亡率有很强的相关性,类似于APACHE II.
- 生物标志物水平的上升趋势比单个测量更能表明预后.
结论:
- 心脏生物标志物可以作为动态指标,用于预测败血症的死亡率和预后.
- 亲脑尿性 (proBNP) 在预测与败血症相关的死亡率方面表现出特别有用.
- 常规监测心脏生物标志物可能会改善患者的治疗和败血症的结果.
更多相关视频
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
